Substance / Medication

Ethanoic acid

Overview

Active Ingredient
acetic acid
RxNorm CUI
168

Indications

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Labeler: Sun Pharmaceutical Industries, Inc.Updated: 2025-07-07T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Hypersensitivity to hydrocortisone and acetic acid otic solution or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

27 trials linked to this intervention

27
Total Trials
4
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Postcesarean Versus Primary Bladder Endometriosis and Coexistent Pelvic Endometriosis: A Systematic Review.
Salmeri Noemi, Buffo Camilla, Ragusi Alessia et al. · J Minim Invasive Gynecol · 2026
PMID: 40825439Meta-Analysis
Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta-analysis.
Corona Giovanni, Capogrosso Paolo, Baldini Sara et al. · BJU Int · 2026
PMID: 41139434Meta-Analysis
The Macedo ileum-based reservoir for the management of bladder involvement in epidermolysis bullosa.
Wiernik Agnieszka, Brauner Paulina, Jastrzębska Magdalena et al. · J Pediatr Urol · 2025
PMID: 39788828Meta-Analysis
Quantifying the impact of bladder complications following gynecological cancer treatment: systematic review and meta-regression.
Rotem Reut, Galvin Daniel, Oprescu Corina et al. · J Gynecol Oncol · 2025
PMID: 40223554Meta-AnalysisFull text (PMC)
Transvaginal mesh or grafts or native tissue repair for vaginal prolapse.
Yeung Ellen, Baessler Kaven, Christmann-Schmid Corina et al. · Cochrane Database Syst Rev · 2024
PMID: 38477494Meta-AnalysisFull text (PMC)
Systematic review of urological injury during caesarean section and hysterectomy.
Wei Gavin, Harley Frances, O'Callaghan Michael et al. · Int Urogynecol J · 2023
PMID: 36251061Meta-AnalysisFull text (PMC)
Iatrogenic bladder injury following gynecologic and obstetric surgery: A systematic review and meta-analysis.
Jensen Ann-Sophie, Heinemeier Ina Isabell Kathleen, Schroll Jeppe Bennekou et al. · Acta Obstet Gynecol Scand · 2023
PMID: 37552010Meta-AnalysisFull text (PMC)
Accuracy of transvaginal ultrasound and magnetic resonance imaging for diagnosis of deep endometriosis in bladder and ureter: a meta-analysis.
Tian Zhao, Zhang Yi-Chao, Sun Xian-Hua et al. · J Obstet Gynaecol · 2022
PMID: 35421318Meta-Analysis
Acupuncture for treating overactive bladder in adults.
Hargreaves Emma, Baker Katherine, Barry Gill et al. · Cochrane Database Syst Rev · 2022
PMID: 36148895Meta-AnalysisFull text (PMC)
Symptoms and Surgical Technique of Bladder Endometriosis: A Systematic Review.
Tomasi Mariana Carpenedo, Ribeiro Paulo Augusto Ayroza, Farah Daniela et al. · J Minim Invasive Gynecol · 2022
PMID: 36252916Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Acetic acid (substance)
SNOMED CT
2869004
UMLS CUI
C0000983
RxNorm CUI
168
Labeler
Sun Pharmaceutical Industries, Inc.

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
27
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.